
Dominick Joseph Angiolillo MD
Adult Congenital Heart Disease, Interventional Cardiology
Professor of Medicine, University of Florida College of Medicine
Join to View Full Profile
655 W 8th St# UfjpJacksonville, FL 32209
Phone+1 904-244-3660
Fax+1 904-244-3425
Dr. Angiolillo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- DOMINICK J. ANGIOLILLO, MD, PHD, FACC, FESC, FSCAI is a Professor of Medicine with Tenure status at the University of Florida. He is also the Director of Cardiovascular Research, Program Director, of the Interventional Cardiology Fellowship program, and Staff Cardiologist and Interventional Cardiologist at the University of Florida Health System. Dr. Angiolillo is triple board certified by the American Board of Internal Medicine (Internal Medicine, Cardiovascular Disease, Interventional Cardiology). Much of Dr. Angiolillo’s professional career has been devoted to cardiovascular research in the field of interventional cardiology and acute coronary syndrome. His largest national and international recognition has been for his pivotal contributions in the field of thrombosis. Since 2014 he has been in the top 1 percent of most-cited researchers worldwide according to Clarivate Analytics (formerly Thomson Reuters’ list of The World’s Most Influential Scientific Minds). Dr. Angiolillo has made major scientific contributions to many medical and cardiovascular journals, as well as textbooks of cardiovascular medicine. His leadership role as an academic clinician scientist has allowed to him to nurture and promote career growth and development of many young trainees pursuing both academic and clinical careers in the United States and abroad. Dr. Angiolillo is an active member of many cardiovascular societies in the Unites States and Europe.
Education & Training
University of FloridaFellowship, Cardiovascular Disease, 2004 - 2007
University of Cattolica del Sacro CuoreClass of 1997
Certifications & Licensure
FL State Medical License 2007 - 2027
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
Clinical Trials
- Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting Start of enrollment: 2008 Sep 01
- Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia Start of enrollment: 2010 Jul 01
- PPI and Clopidogrel Response Start of enrollment: 2009 Mar 01
Publications & Presentations
PubMed
- 3 citationsAspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?Mattia Galli, Jurrien Ten Berg, Marco Valgimigli, Davide Capodanno, Felice Gragnano
European Heart Journal. 2026-02-09 - Timing of Ticagrelor Administration and Graft Failure After Coronary Artery Bypass Surgery.Sigrid Sandner, Björn Redfors, Melanie Arnreiter, Dominick J Angiolillo, Joyce Peper
European Journal of Cardio-Thoracic Surgery. 2026-02-05 - Impact of Area-Level Socioeconomic Deprivation on Post-PCI Outcomes Stratified by P2YInhibitor Therapy.Jean G Malavé, Cameron D Thomas, Francesco Franchi, Ellen C Keeley, Caitrin W McDonough
JACC. Advances. 2026-02-03
Journal Articles
- Reply P2Y12 Inhibitor–Based Monotherapy: Optimal Duration and Ideal AgentDominick Angiolillo, MD, JACC: Cardiovascular Imaging
- Coronary Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary AngiographySomjot Brar, Hitinder S Gurm, Barry Bertolet, Anand Prasad, Dominick J Angiolillo, Roxana Mehran, George Dangas, Wayne Batchelor, Gregg W Stone, ScienceDirect
- Research Letter Ticagrelor Versus Clopidogrel for Recovery of Vascular Function Immediately After Successful Chronic Coronary Total Occlusion Recanalization: A Randomi...Dominick Angiolillo, MD, ScienceDirect
Lectures
- Take Home for Clinicians: DM and STEMICRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- Cardioprevention in Primary Care: Where Does Aspirin Fit In?
- Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Authored Content
- Reply P2Y12 Inhibitor–Based Monotherapy: Optimal Duration and Ideal AgentSeptember 2020
- Ticagrelor with or Without Aspirin in High-Risk Patients with Diabetes Mellitus Undergoing Percutaneous Coronary InterventionMay 2020
- Ticagrelor with or Without Aspirin in High-Risk Patients with Diabetes Mellitus Undergoing Percutaneous Coronary InterventionMay 2020
Press Mentions
What Now for Factor XI Inhibitors in AF?December 11th, 2024
Aspirin Hypersensitivity in Patients with Atherosclerotic Cardiovascular DiseaseOctober 21st, 2024
Prolocor, Slingshot Bioscience Publish Paper on Prognostic Tool to Help Assess Thrombosis RiskSeptember 10th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









